Alcidion (ASX:ALC) share price hits 52-week high on record sales

The Alcidion (ASX:ALC) share price has pushed nearly 9% higher after the company reported strong growth underpinned by an upbeat outlook.

| More on:
A happy doctor in a white coat dancing due to his excitement over the EBOS acquisition

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Alcidion Group Ltd (ASX: ALC) shares are on the rise today after the company recorded one of its strongest sales periods to date. At the time of writing, the Alcidion share price has jumped 8.7% to 25 cents.

Let's take a look at how the tech company has been performing.

Alcidion share price surges on strong earnings 

The Alcidion share price is running higher today following the company delivering strong earnings growth during the first half of FY21 (1H21). Alcidion reported that revenue for the period increased by 36% to $11.1 million. 

The company added $17.4 million in contracted revenue in the first half, one of its strongest sales periods to date. A further $23.0 million of sold revenue will also be recognised over the next five years from FY22 to FY26. 

Significant contracts were signed in the United Kingdom and Australia, including with NHS Trust for Alcidion's largest-ever smart clinical solution, Miya Precision. Other significant contract wins include 12-month contracts signed with New South Wales Government local health districts Murrumbidgee and Sydney. 

Strong revenue growth also translated into an improved earnings before interest, tax, depreciation, and amortisation (EBITDA) loss of $912,000 compared to a $1.7 million EBITDA loss in 1H20. 

Upbeat outlook  

Alcidion believes it is advantageously positioned for the second half of FY21, with the health IT sales environment progressively returning to pre-COVID-19 levels. 

The company's current sales revenue is growing strongly and is on track to surpass FY20 revenue. Contracted revenue in FY21 is already 17% higher than the year prior with four months of the year still remaining. 

The company is upbeat about its sales pipeline, citing new and existing customers in all markets being underpinned by a strong recovery in health IT procurement. 

Company snapshot

Alcidion helps healthcare organisations leverage the power of technology to create a clinically relevant environment with digitally enabled care. The company's flagship product is its Miya Precision solution that facilitates multiple clinical and operational applications. 

Over the past twelve months, the Alcidion share price has jumped by nearly 39%. Year to date, Alcidion shares are trading nearly 32% higher.

Based on the current share price, the company commands a market capitalisation of around $248 million.

Kerry Sun has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Alcidion Group Ltd. The Motley Fool Australia has recommended Alcidion Group Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

A man analyses stockmarket graph on his computer.
52-Week Lows

The Guzman Y Gomez share price hit a 52-week low this week. Is it a buy?

Has this stock lost its spice or is it set to rebound?

Read more »

Man sitting in a plane looking through a window and working on a laptop.
Broker Notes

Should you buy Qantas shares before reporting season? Here's what Macquarie recommends

We look at Macquarie’s expectations for the surging Qantas share price in FY 2026.

Read more »

Contented looking man leans back in his chair at his desk and smiles.
Share Market News

5 things to watch on the ASX 200 on Thursday

Here's what to expect on the local market today.

Read more »

A set of scales with a bag of money balanced against a timer, indicating growth versus value shares
Opinions

Which ASX sector offers the best value heading into earnings season?

I think one sector is particularly compelling.

Read more »

Green stock market graph.
Share Gainers

Here are the top 10 ASX 200 shares today

It was one for the history books today.

Read more »

Person holding a blue chip.
Blue Chip Shares

4 ASX 200 blue-chip shares to hold but not buy: experts

These blue-chips are worth holding if you already own them, but are too expensive for new investors to buy.

Read more »

A bricklayer peeps over the top of a brick wall he is laying with a level measuring tool on top.
Broker Notes

Are Brickworks shares a buy, hold or sell ahead of earnings season?

Brokers have been weighing property gains, US headwinds, and merger impacts to form a view.

Read more »

A man in his office leans back in his chair with his hands behind his head looking out his window at the city, sitting back and relaxed, confident in his ASX share investments for the long term.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »